A Senate committee has backed new medicines shortage legislation despite warnings it will regulate notification of drug withdrawals without requiring suppliers to maintain supply or arrange alternatives.
A Senate committee has backed new medicines shortage legislation despite warnings it will regulate notification of drug withdrawals without requiring suppliers to maintain supply or arrange alternatives.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.